Pfizer Inc (PFE)
MSN Money Report
QUOTE DETAIL
| After Hours: 22.35 -0.03 / -0.16% Vol. 636,028 | |||
22.39  -0.16 -0.69% | |||
|---|---|---|---|
| Volume | 30.37 Mil | PFE Intraday Chart NYSE Exchange Data Source: CSI 10:22 PM ET Quotes delayed 15 minutes | |
| Avg Daily Volume | 38.28 Mil | ||
| Day's High | 22.45 | ||
| Day's Low | 22.25 | ||
| Open | 22.42 | ||
| Previous Close | 22.54 | ||
| Bid | 22.00 | ||
| Bid Size | 100 | ||
| Ask | 26.99 | ||
| Ask Size | 200 | Current Div. Yield | 3.90 |
| 52 Week High | 22.80 | Market Cap. | 168.7 Bil |
| 52 Week Low | 16.63 | Tot. Shares Out. | 7.537 Bil |
| Instit. Ownership | 70.5% | Forward P/E | 10.00 |
| fyi P/E | 20.40 | Sales | 67.43 Bil |
| Earnings/Share | 1.27 | Return on Equity | 10.24 |
| Div/Share | 0.88 | Beta | 0.72 |
Last trade (extended hours) 07:01 PM ET
NEWS & ANALYSIS
|
OPTIONS
APRIL 21, 2012 CALLSShaded options are in-the-money
| Strike Price | Symbol | Last | Chg | %Chg | Time Value | Bid | Ask | Vol | Open Interest |
|---|---|---|---|---|---|---|---|---|---|
| 12.000 | .PFE\12D21\12.0 | NA | NA | NA | NA | 10.350 | 10.450 | NA | NA |
| 13.000 | .PFE\12D21\13.0 | 8.600 | NA | NA | 0.060 | 9.350 | 9.450 | NA | 109 |
| 13.000 | .PFE\12D05\13.0 | NA | NA | NA | NA | 9.300 | 9.450 | NA | NA |
| 14.000 | .PFE\12D21\14.0 | 7.450 | NA | NA | 0.060 | 8.350 | 8.450 | NA | 3 |
| 14.000 | .PFE\12D05\14.0 | NA | NA | NA | NA | 8.300 | 8.450 | NA | NA |
| 15.000 | .PFE\12D21\15.0 | 6.150 | NA | NA | 0.060 | 7.350 | 7.450 | NA | 616 |
| 15.000 | .PFE\12D05\15.0 | NA | NA | NA | NA | 7.300 | 7.450 | NA | NA |
| 16.000 | .PFE\12D21\16.0 | 6.610 | NA | NA | 0.060 | 6.350 | 6.450 | NA | 1,051 |
| 16.000 | .PFE\12D05\16.0 | NA | NA | NA | NA | 6.300 | 6.450 | NA | NA |
| 17.000 | .PFE\12D21\17.0 | 5.650 | NA | NA | 0.060 | 5.350 | 5.450 | NA | 25 |
| 17.000 | .PFE\12D05\17.0 | NA | NA | NA | NA | 5.300 | 5.450 | NA | NA |
| 18.000 | .PFE\12D21\18.0 | 4.550 | NA | NA | 0.060 | 4.350 | 4.450 | NA | 200 |
| 18.000 | .PFE\12D05\18.0 | NA | NA | NA | NA | 4.350 | 4.450 | NA | NA |
| 19.000 | .PFE\12D21\19.0 | 3.350 | -0.10 | -2.90% | 0.060 | 3.350 | 3.450 | 1 | 825 |
| 19.000 | .PFE\12D05\19.0 | NA | NA | NA | NA | 3.350 | 3.450 | NA | NA |
| 20.000 | .PFE\12D21\20.0 | 2.440 | -0.09 | -3.56% | 0.040 | 2.380 | 2.430 | 56 | 2,681 |
| 20.000 | .PFE\12D05\20.0 | 2.280 | -0.32 | -12.31% | 0.030 | 2.370 | 2.420 | 1 | 6 |
| 21.000 | .PFE\12D21\21.0 | 1.400 | -0.13 | -8.50% | 0.020 | 1.390 | 1.410 | 17,718 | 39,064 |
| 21.000 | .PFE\12D05\21.0 | 1.290 | -0.31 | -19.38% | 0.030 | 1.370 | 1.420 | 50 | 53 |
| 22.000 | .PFE\12D21\22.0 | 0.540 | +0.01 | +1.89% | 0.120 | 0.500 | 0.510 | 1,268 | 42,957 |
| 22.000 | .PFE\12D05\22.0 | 0.310 | -0.25 | -44.64% | 0.010 | 0.370 | 0.400 | 155 | 511 |
| 23.000 | .PFE\12D21\23.0 | 0.070 | -0.02 | -22.22% | 0.070 | 0.060 | 0.070 | 350 | 17,661 |
| 23.000 | .PFE\12D05\23.0 | 0.040 | NA | NA | 0.020 | NA | 0.020 | NA | 546 |
| 24.000 | .PFE\12D21\24.0 | 0.020 | NA | NA | 0.020 | NA | 0.020 | NA | 3,773 |
| 24.000 | .PFE\12D05\24.0 | NA | NA | NA | NA | NA | 0.020 | NA | NA |
| 25.000 | .PFE\12D21\25.0 | 0.020 | NA | NA | 0.010 | NA | 0.010 | NA | 192 |
| 25.000 | .PFE\12D05\25.0 | NA | NA | NA | NA | NA | 0.020 | NA | NA |
| 26.000 | .PFE\12D21\26.0 | 0.010 | NA | NA | 0.010 | NA | 0.010 | NA | 289 |
| 26.000 | .PFE\12D05\26.0 | NA | NA | NA | NA | NA | 0.020 | NA | NA |
| 27.000 | .PFE\12D21\27.0 | NA | NA | NA | NA | NA | 0.010 | NA | NA |
| 27.000 | .PFE\12D05\27.0 | NA | NA | NA | NA | NA | 0.020 | NA | NA |
| 28.000 | .PFE\12D21\28.0 | NA | NA | NA | NA | NA | 0.010 | NA | NA |
| 28.000 | .PFE\12D05\28.0 | NA | NA | NA | NA | NA | 0.020 | NA | NA |
| 29.000 | .PFE\12D21\29.0 | NA | NA | NA | NA | NA | 0.010 | NA | NA |
| 29.000 | .PFE\12D05\29.0 | NA | NA | NA | NA | NA | 0.020 | NA | NA |
| 30.000 | .PFE\12D05\30.0 | NA | NA | NA | NA | NA | 0.020 | NA | NA |
| 31.000 | .PFE\12D05\31.0 | NA | NA | NA | NA | NA | 0.020 | NA | NA |
APRIL 21, 2012 PUTSShaded options are in-the-money
| Strike Price | Symbol | Last | Chg | %Chg | Time Value | Bid | Ask | Vol | Open Interest |
|---|---|---|---|---|---|---|---|---|---|
| 12.000 | .PFE\12P21\12.0 | 0.010 | NA | NA | 0.010 | NA | 0.010 | NA | 185 |
| 13.000 | .PFE\12P21\13.0 | 0.010 | NA | NA | 0.010 | NA | 0.010 | NA | 35 |
| 13.000 | .PFE\12P05\13.0 | NA | NA | NA | NA | NA | 0.020 | NA | NA |
| 14.000 | .PFE\12P21\14.0 | 0.030 | NA | NA | 0.010 | NA | 0.010 | NA | 4 |
| 14.000 | .PFE\12P05\14.0 | NA | NA | NA | NA | NA | 0.020 | NA | NA |
| 15.000 | .PFE\12P21\15.0 | 0.010 | NA | NA | 0.010 | NA | 0.010 | NA | 367 |
| 15.000 | .PFE\12P05\15.0 | NA | NA | NA | NA | NA | 0.020 | NA | NA |
| 16.000 | .PFE\12P21\16.0 | 0.010 | NA | NA | 0.010 | NA | 0.010 | NA | 444 |
| 16.000 | .PFE\12P05\16.0 | NA | NA | NA | NA | NA | 0.020 | NA | NA |
| 17.000 | .PFE\12P21\17.0 | 0.010 | NA | NA | 0.010 | NA | 0.010 | NA | 18,480 |
| 17.000 | .PFE\12P05\17.0 | NA | NA | NA | NA | NA | 0.020 | NA | NA |
| 18.000 | .PFE\12P21\18.0 | 0.020 | NA | NA | 0.010 | NA | 0.010 | NA | 1,859 |
| 18.000 | .PFE\12P05\18.0 | NA | NA | NA | NA | NA | 0.020 | NA | NA |
| 19.000 | .PFE\12P21\19.0 | 0.010 | NA | NA | 0.010 | NA | 0.010 | NA | 2,780 |
| 19.000 | .PFE\12P05\19.0 | NA | NA | NA | NA | NA | 0.020 | NA | NA |
| 20.000 | .PFE\12P21\20.0 | 0.020 | NA | NA | 0.020 | 0.010 | 0.020 | NA | 6,034 |
| 20.000 | .PFE\12P05\20.0 | NA | NA | NA | NA | NA | 0.020 | NA | NA |
| 21.000 | .PFE\12P21\21.0 | 0.020 | +0.01 | +100.00% | 0.020 | 0.010 | 0.020 | 50 | 19,032 |
| 21.000 | .PFE\12P05\21.0 | NA | NA | NA | NA | NA | 0.020 | NA | NA |
| 22.000 | .PFE\12P21\22.0 | 0.120 | +0.01 | +9.09% | 0.130 | 0.110 | 0.130 | 302 | 20,790 |
| 22.000 | .PFE\12P05\22.0 | 0.020 | NA | NA | 0.020 | NA | 0.020 | NA | 107 |
| 23.000 | .PFE\12P21\23.0 | 0.770 | +0.12 | +18.46% | 0.080 | 0.660 | 0.690 | 479 | 1,762 |
| 23.000 | .PFE\12P05\23.0 | 0.420 | NA | NA | 0.030 | 0.590 | 0.640 | NA | 757 |
| 24.000 | .PFE\12P21\24.0 | 1.520 | NA | NA | 0.020 | 1.600 | 1.630 | NA | 1,653 |
| 24.000 | .PFE\12P05\24.0 | NA | NA | NA | NA | 1.540 | 1.640 | NA | NA |
| 25.000 | .PFE\12P21\25.0 | 2.520 | NA | NA | 0.020 | 2.590 | 2.630 | NA | 141 |
| 25.000 | .PFE\12P05\25.0 | NA | NA | NA | NA | 2.540 | 2.640 | NA | NA |
| 26.000 | .PFE\12P21\26.0 | 4.250 | NA | NA | 0.040 | 3.550 | 3.650 | NA | 42 |
| 26.000 | .PFE\12P05\26.0 | NA | NA | NA | NA | 3.500 | 3.650 | NA | NA |
| 27.000 | .PFE\12P21\27.0 | 5.800 | NA | NA | 0.040 | 4.550 | 4.650 | NA | NA |
| 27.000 | .PFE\12P05\27.0 | NA | NA | NA | NA | 4.500 | 4.650 | NA | NA |
| 28.000 | .PFE\12P21\28.0 | NA | NA | NA | NA | 5.550 | 5.650 | NA | NA |
| 28.000 | .PFE\12P05\28.0 | NA | NA | NA | NA | 5.500 | 5.650 | NA | NA |
| 29.000 | .PFE\12P21\29.0 | 6.950 | NA | NA | 0.040 | 6.550 | 6.650 | NA | NA |
| 29.000 | .PFE\12P05\29.0 | NA | NA | NA | NA | 6.500 | 6.650 | NA | NA |
| 30.000 | .PFE\12P05\30.0 | NA | NA | NA | NA | 7.500 | 7.700 | NA | NA |
| 31.000 | .PFE\12P05\31.0 | NA | NA | NA | NA | 8.500 | 8.700 | NA | NA |
1 YEAR CHART
COMPANY REPORT
Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health and Consumer Healthcare, and Nutrition. The Company’s diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Its Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. On August 1, 2011, it completed the sale of its Capsugel business. In October 2011, it acquired Icagen, Inc. In December 2011, it acquired the consumer healthcare business of Ferrosan Holding A/S. In December 2011, it acquired Excaliard Pharmaceuticals, Inc.
STOCK ACTIVITY
| Last Price | 22.3850002288818 |
| 52 Week High | 22.80 |
| 52 Week Low | 16.63 |
| Volume | 30.37 Mil |
| Average Daily Volume (13wk) | 38.28 Mil |
| 50 Day Moving Average | 21.57 |
| 200 Day Moving Average | 20.04 |
| Volatility (beta) | 0.72 |
Financial data in U.S. dollars
STOCK PRICE HISTORY
| Change | Relative Strength | |
|---|---|---|
| Last 3 Months | 2.6% | 40 |
| Last 6 Months | 28.1% | 68 |
| Last 12 Months | 9.7% | 76 |
INSTITUTIONAL STATISTICS
| Analyst Consensus | Moderate Buy |
| Institutional Ownership | 70.50% |
QUICK FACTS
| Location | 235 East 42nd Street NEW YORK NY 10017-5755 Phone: 212-7332323 Fax: 302-6555049 |
| Web Site | http://www.pfizer.com |
| Industry | Drug Manufacturers - Major |
| Employees | 103,700 |
| Exchange | NYSE |
FINANCIALS
| Last 12 Months | 5 Year Growth | |
|---|---|---|
| Sales | 67.4 Bil | 6.9% |
| Income | 8.7 Bil | -4.6% |
| Dividend Rate | 0.88 | -3.58% |
| Dividend Yield | 3.90% | 4.90% |
FUNDAMENTAL DATA
| Debt/Equity Ratio | 0.47 |
| Gross Margin | 77.63% |
| Net Profit Margin | 12.96% |
| Total Shares Outstanding | 7.5 Bil |
| Market Capitalization | 168.73 Bil |
| Earnings/Share | 1.27 |
| StockScouter Rating | 5 |
EARNINGS ESTIMATES
| Qtr(3/12) EPS Estimate | 0.56 |
| FY(12/12) EPS Estimate | 2.26 |
| Current P/E | 20.40 |
| FY(12/13) EPS Estimate | 2.36 |
| Forward P/E | 9.49 |
OWNERSHIP INFORMATION
| Shares Outstanding | 7.54 Bil |
| Institutional Ownership (%) | 70.50 |
| Top 10 Institutions (%) | 21.60 |
| Mutual Fund Ownership (%) | 1.73 |
| 5%/Insider Ownership (%) | 26.00 |
| Float (%) | 74.00 |
OWNERSHIP ACTIVITY
| Description | # of Holders | Shares |
|---|---|---|
| Total Positions | 1,618 | 5,313,455,616 |
| New Positions | 122 | 0 |
| Soldout Positions | 226 | 0 |
| Net Position Change | -279 | -242,229,760 |
| Buyers | 697 | 226,752,912 |
| Sellers | 976 | -468,982,688 |
EARNINGS ESTIMATES
| Qtr(3/12) | Qtr(6/12) | FY(12/12) | FY(12/13) | |
|---|---|---|---|---|
| Average Estimate | 0.56 | 0.56 | 2.26 | 2.36 |
| Number of Analysts | 13 | 13 | 18 | 16 |
| High Estimate | 0.61 | 0.59 | 2.31 | 2.50 |
| Low Estimate | 0.53 | 0.52 | 2.20 | 2.24 |
| Year Ago EPS | 0.60 | 0.60 | 2.31 | 2.26 |
| Growth Rate | -6.15% | -6.03% | -2.16% | +4.23% |
Financial data in U.S. dollars
EARNINGS SURPRISE
| (12/10) | (3/11) | (6/11) | (9/11) | (12/11) | |
|---|---|---|---|---|---|
| Estimate | 0.46 | 0.58 | 0.59 | 0.56 | 0.47 |
| Actual | 0.47 | 0.60 | 0.60 | 0.62 | 0.50 |
| Difference | 0.01 | 0.02 | 0.01 | 0.06 | 0.03 |
| % Change | +2.17% | +3.45% | +1.69% | +10.71% | +6.38% |
Financial data in U.S. dollars
EARNINGS GROWTH RATES
| Last 5 Years | FY 2012 | FY 2013 | Next 5 Years | 12 P/E | |
|---|---|---|---|---|---|
| Company | +2.00% | -2.20% | +4.20% | +3.80% | 10.00 |
| Industry | +11.30% | +1.20% | +5.00% | +5.70% | 13.60 |
| S&P 500 | NA | NA | +5.80% | NA | 14.60 |
CONSENSUS EPS TREND
| Qtr(3/12) | Qtr(6/12) | FY(12/12) | FY(12/13) | |
|---|---|---|---|---|
| Current Estimate | 0.56 | 0.56 | 2.26 | 2.36 |
| 7 Days Ago | 0.56 | 0.56 | 2.26 | 2.36 |
| 30 Days Ago | 0.56 | 0.56 | 2.26 | 2.36 |
| 60 Days Ago | 0.56 | 0.57 | 2.26 | 2.35 |
| 90 Days Ago | 0.57 | 0.57 | 2.30 | 2.39 |
Financial data in U.S. dollars
Zacks average brokerage recommendation is Moderate Buy.
ANALYST RATINGS
| Recommendations | Current | 1 Month Ago | 2 Months Ago | 3 Months Ago |
|---|---|---|---|---|
| Strong Buy | 13 | 13 | 13 | 13 |
| Moderate Buy | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.32 | 1.32 | 1.32 | 1.32 |
| 1.0 = | Strong Buy |
| 1.1 thru 2.0 = | Moderate Buy |
| 2.1 thru 3.0 = | Hold |
| 3.1 thru 4.0 = | Moderate Sell |
| 4.1 thru 5.0 = | Strong Sell |
FINANCIAL HIGHLIGHTS
| Sales | 67.43 Bil | Revenue/Share | 8.57 |
| Income | 8.70 Bil | Earnings/Share | 1.27 |
| Net Profit Margin | 12.96% | Book Value/Share | 10.85 |
| Return on Equity | 10.24% | Dividend Rate | 0.88 |
| Debt/Equity Ratio | 0.47 | Payout Ratio | 71.00% |
REVENUE - QUARTERLY RESULTS (IN MILLIONS)
QTR. OVER QTR. EPS GROWTH RATE
| EARNINGS PER SHARE - QUARTERLY RESULTS
YR. OVER YR. EPS GROWTH RATE
|
Financial data in U.S. dollars
Financial data in U.S. dollars
| Growth Rates % | Company | Industry | S&P 500 |
|---|---|---|---|
| Sales (Qtr vs year ago qtr) | -3.50 | 2.00 | 10.00 |
| Net Income (YTD vs YTD) | NA | NA | NA |
| Net Income (Qtr vs year ago qtr) | -48.60 | 77.70 | 47.80 |
| Sales (5-Year Annual Avg.) | 6.87 | 6.77 | 8.14 |
| Net Income (5-Year Annual Avg.) | -4.63 | 5.76 | 8.17 |
| Dividends (5-Year Annual Avg.) | -3.58 | 8.23 | 5.00 |
| Price Ratios | Company | Industry | S&P 500 |
|---|---|---|---|
| Current P/E Ratio | 20.4 | 16.3 | 39.1 |
| P/E Ratio 5-Year High | NA | 20.5 | 13.9 |
| P/E Ratio 5-Year Low | NA | 3.9 | 3.1 |
| Price/Sales Ratio | 2.52 | 3.19 | 2.34 |
| Price/Book Value | 2.08 | 4.34 | 12.43 |
| Price/Cash Flow Ratio | 9.60 | 10.40 | 12.40 |
| Profit Margins % | Company | Industry | S&P 500 |
|---|---|---|---|
| Gross Margin | 77.6 | 69.7 | 39.4 |
| Pre-Tax Margin | 18.9 | 8.4 | 17.8 |
| Net Profit Margin | 13.0 | 16.2 | 13.0 |
| 5Yr Gross Margin (5-Year Avg.) | 79.1 | 70.7 | 39.5 |
| 5Yr PreTax Margin (5-Year Avg.) | 18.4 | 7.9 | 15.8 |
| 5Yr Net Profit Margin (5-Year Avg.) | 14.9 | 3.4 | 11.4 |
| Financial Condition | Company | Industry | S&P 500 |
|---|---|---|---|
| Debt/Equity Ratio | 0.47 | 0.92 | 2.04 |
| Current Ratio | 2.1 | 1.7 | 1.4 |
| Quick Ratio | 1.8 | 1.4 | 0.9 |
| Interest Coverage | 11.4 | 30.8 | 33.1 |
| Leverage Ratio | 2.3 | 2.9 | 5.7 |
| Book Value/Share | 10.85 | 16.26 | 27.32 |
| Investment Returns % | Company | Industry | S&P 500 |
|---|---|---|---|
| Return On Equity | 10.2 | 59.5 | 28.2 |
| Return On Assets | 4.6 | 9.2 | 8.7 |
| Return On Capital | 5.4 | 12.4 | 11.6 |
| Return On Equity (5-Year Avg.) | 11.0 | 22.8 | 24.6 |
| Return On Assets (5-Year Avg.) | 5.3 | 9.7 | 8.1 |
| Return On Capital (5-Year Avg.) | 6.5 | 13.0 | 10.9 |
| Management Efficiency | Company | Industry | S&P 500 |
|---|---|---|---|
| Income/Employee | 84,272 | 89,236 | 131,446 |
| Revenue/Employee | 650,193 | 540,582 | 1 Mil |
| Receivable Turnover | 5.0 | 5.7 | 14.9 |
| Inventory Turnover | 1.9 | 2.9 | 12.6 |
| Asset Turnover | 0.4 | 0.6 | 0.8 |
| Avg P/E | Price/ Sales | Price/ Book | Net Profit Margin (%) | |
|---|---|---|---|---|
| 12/11 | 17.70 | 2.53 | 1.99 | 12.9 |
| 12/10 | 16.50 | 2.11 | 1.60 | 12.2 |
| 12/09 | 13.10 | 2.60 | 1.63 | 17.3 |
| 12/08 | 16.20 | 2.48 | 2.08 | 16.6 |
| 12/07 | 21.30 | 3.26 | 2.36 | 17.0 |
| 12/06 | 17.00 | 3.89 | 2.59 | 22.8 |
| 12/05 | 24.80 | 3.65 | 2.61 | 16.0 |
| 12/04 | 22.90 | 4.18 | 2.94 | 22.3 |
| 12/03 | 142.80 | 5.75 | 4.12 | 3.6 |
| 12/02 | 23.80 | 5.91 | 9.44 | 28.4 |
| Book Value/ Share | Debt/ Equity | Return on Equity (%) | Return on Assets (%) | Interest Coverage | |
|---|---|---|---|---|---|
| 12/11 | $10.85 | 0.47 | 10.6 | 4.6 | 7.6 |
| 12/10 | $10.96 | 0.50 | 9.3 | 4.2 | 5.2 |
| 12/09 | $11.15 | 0.54 | 9.5 | 4.0 | 8.7 |
| 12/08 | $8.53 | 0.30 | 13.9 | 7.2 | 18.8 |
| 12/07 | $9.62 | 0.20 | 12.6 | 7.1 | 23.4 |
| 12/06 | $10.02 | 0.11 | 15.4 | 9.5 | 26.7 |
| 12/05 | $8.93 | 0.27 | 11.6 | 6.5 | 22.9 |
| 12/04 | $9.14 | 0.27 | 16.0 | 8.9 | 38.6 |
| 12/03 | $8.57 | 0.22 | 2.5 | 1.4 | 12.0 |
| 12/02 | $3.24 | 0.59 | 45.9 | 19.8 | 46.9 |
Industry: Drug Manufacturers - Major
Computed ratios are based on latest 12 months' results.